Related by context. Frequent words. (Click for all words.) 57 randomized Phase III 57 ATTRACT 57 Phase III randomized 56 phase IIa 56 active comparator 55 placebo controlled clinical 55 substudy 55 Phase 2a clinical 55 Phase 1b clinical 55 double blinded placebo 54 Phase 1a 54 LymphoStat B 54 multicentre 54 Phase 1b trial 53 multicenter clinical 53 secondary efficacy endpoints 53 prospective randomized controlled 53 Phase 1b 53 Phase 2a trial 53 noninferiority 53 RTOG 53 multicenter randomized 53 multicenter 53 Phase 2b 53 multicenter randomized double 53 phase IIb 53 DURATION 52 Phase Ia 52 abatacept 52 Phase 2b study 52 Phase 2a 52 PROPEL 52 nab paclitaxel 52 Phase III pivotal 52 relapsed refractory multiple myeloma 52 TRITON TIMI 52 Phase IIa clinical 52 TELCYTA 52 Phase Ib 52 randomized controlled clinical 52 phase 2a 52 Phase 2b clinical 51 evaluable patients 51 evaluable 51 non inferiority 51 median PFS 51 NRTI 51 achieved statistical significance 51 placebo controlled randomized 51 randomized placebo controlled 51 pharmacodynamic 51 sunitinib 51 sustained virologic response 51 ZYBRESTAT 51 RG# [001] 50 virologic response 50 Initiates Phase 50 randomized Phase 50 label dose escalation 50 Phase III 50 decitabine 50 mg kg dose 50 Alemtuzumab 50 azacitidine 50 PEG Interferon lambda 50 PXD# 50 tesmilifene 50 Phase 2b trial 50 multiple ascending dose 50 Phase IIb clinical 50 primary endpoints 50 Restanza 50 EORTC 50 placebo controlled 50 Phase IIa 50 dose escalation trial 50 Ostarine 49 romidepsin 49 axitinib 49 pharmacokinetic studies 49 ACHIEVE 49 vicriviroc 49 ASCENT 49 National Surgical Adjuvant 49 ECOG 49 RECIST criteria 49 Phenoptin 49 STELLAR 49 Clinical Trial Results 49 ocrelizumab 49 confirmatory Phase III 49 INGN 49 randomized controlled 49 placebo controlled trials 49 ASA# 49 Phase IIa trial 48 HuMax CD# 48 Phase II 48 Lenalidomide 48 HGS ETR1 48 IMC A#